IP Strategy: Protection, Execution, and the Open Alternative

What you will learn

• Understand the four main IP tools (patents, trademarks, trade secrets, copyright) and the disclosure bargain behind them
• Map the three-stage IP journey, from execution-first through selective protection to a defensive portfolio
• Weigh the open alternative (publication, open source, consortium models) as a strategic choice rather than a concession
• Name the one IP decision your own work is facing in the next 12 months

Read: The Basics of IP Protection

IP law makes a bargain with inventors: if you disclose your innovation fully, we'll give you a temporary monopoly (typically 20 years for patents) to commercialise it. After that, the knowledge is public. The idea is to encourage sharing over secrecy-and to reward the risk of R&D investment with an enforced monopoly.

Four main tools:

The catch: Patents require full public disclosure. Once you file, competitors can read exactly how your invention works-often before you've brought your work to the market.

Read: The Three-Stage IP Journey

Stage 1, Execution First (0–2 years) Early on, your competitive advantage is speed and expertise. A patent costs $15–50K internationally, takes 2–4 years to grant, and requires disclosing your approach to the innovation publicly. Meanwhile, your technology may evolve or become obsolete. Many successful early-stage ventures win by building faster and serving customers better than anyone else as their priority.

Stage 2, Selective Protection (2–5 years) Once you've validated your market and proven your model, your innovations are worth protecting. Competitors will have noticed. You can file patents on core differentiators. These are things that would genuinely harm your business if copied. You'll also want to start monitoring what competitors are filing. Consider which international markets matter to your business the most.

Stage 3, Defensive Portfolio (5+ years) At scale, IP protection becomes infrastructure. You need a portfolio not primarily to attack competitors, but to defend against patent trolls and enable cross-licensing deals. Patents become a negotiation tool you use in licensing deals. Freedom-to-operate matters globally. IP portfolios affect acquisition valuations and investment due diligence, so depending on your exit strategy, plan accordingly.

Read: The Open Alternative

Open source and research publication create prior art-public records that prevent anyone from later patenting the same idea. This is a powerful defensive tool:

• Linux created such extensive prior art through open development that proprietary OS patents couldn't block the entire ecosystem.
• IBM famously pivoted in 2000, investing $1 billion in Linux and open source. By 2010, this drove $60B+ in annual services revenue-far exceeding what they'd earned from patent licensing. Their open source credibility enabled the $34B Red Hat acquisition.
• Tesla opened all its patents in 2014, reasoning that network effects and infrastructure mattered more than exclusivity. The EV industry accelerated; Tesla maintained leadership.

Non-profit and consortium models let multiple organisations share R&D costs and IP risk. Open Invention Network, Apache Software Foundation, and Creative Commons each demonstrate ways to build collectively without anyone owning the core. These models can attract corporate R&D funding if they have governance models which let supporters feel "in control" of strategic directions and efforts. Fiscal sponsorship by a larger umbrella non-profit such as the Gift Collective (NZ), The Linux Foundation (US), Community Initiatives (US), NUMFOCUS (US) and others can help you bootstrap or launch an non-profit project with minimal expense.

Monetising open source software directly is not usually the approach that works. Successful models layer services, development efforts, feature bounties, support, hosting, or premium features on top of an open core. So consider what your "open core" would be and how it plays into your strategic moats.

Case Studies

IBM's Open Source Transformation (2000–2010) In the 1990s IBM held 40,000+ patents and earned $1 billion annually in licensing. By 2000, their proprietary software was losing to nimbler competitors. IBM made a $1 billion bet on Linux-contributing thousands of patents to open source, releasing major software components under open licences, and pivoting from selling licences to selling services. Critics called it suicide. By 2010, IBM's services revenue exceeded $60 billion annually. The strategy culminated in the $34B acquisition of Red Hat in 2019.

Theranos and the Patent Mirage (2003–2018) Theranos built a $9 billion valuation on 800+ patent applications. CEO Elizabeth Holmes cited the patent portfolio as proof of competitive moat. But the patents covered theoretical approaches to blood testing-there was no working technology behind them. When the deception unravelled, the IP portfolio was worthless. Holmes was convicted of fraud and sentenced to 11+ years. Patents without execution create no value, and can mask dangerous gaps.

Reflection Prompts (bring your answers to the session)

1. What stage of the IP journey does your current work or venture idea occupy, and what's the one piece of evidence that convinced you?
2. Is there something in your research you'd rather publish than patent-and why?
3. Who in your field has built a moat through execution rather than IP? How?

Start here. Discussion 1 works from the three reflection prompts you answered in the pre-work, so they are below in your own words.

Before You Begin

Discussion 1: The Assumption Check (10 min)

Discussion 2: The IBM Question (10 min)

Prompt for small groups:

IBM had 40,000 patents and $1 billion in annual licensing revenue, then gave most of it away and made far more money.

Discussion 3: The Theranos Mirror (10 min)

Prompt:

Theranos had 800+ patents and no working product.

Discussion 4: Stage Mapping (15 min)

Discussion 5: The Decision You're Avoiding (10 min)

Wrap-Up (5 min)

Do this within a week of the session. This is for you, not for a grade.

Your IP Strategy Audit

Work through these questions for one piece of research, idea, or project you're actively developing (or could imagine developing):

Part 1, Stage Assessment

• Which stage are you in? (Execution Focus / Selective Protection / Defensive Portfolio)
• What is your primary competitive advantage right now: speed, expertise, relationships, or IP?
• What would it cost (integrated effort, time, capital equipment etc.) a well-resourced competitor to replicate what you do?

Part 2, What's Worth Protecting

• Is there one specific innovation that, if copied, would seriously damage your business or project?
• Would a patent, trade secret, trademark, or copyright best protect it?
• What does protection cost vs. what does exposure cost?

Part 3, The Open Alternative

• Would open-sourcing or publishing your core method accelerate your goals rather than undermine them? (Think: building a community, creating prior art, attracting collaborators)
• Is there a non-profit or consortium model that would let you focus on the work you love while others worry about the business model?
• How would you hold-on to the strategic direction of this more open work?

Part 4, Your One Decision Complete these sentences: The most important IP decision facing my work in the next 12 months is ______. My current instinct is ______. What I'm uncertain about is ______.

Bring Part 4 to your next mentoring check-in.

Key Concepts Reference

Prior art: Any publicly available evidence that an invention already existed before a patent was filed. Creates a legal defence against patent claims.

Freedom to operate (FTO): Analysis of whether you can commercialise a product without infringing existing patents.

Patent Cooperation Treaty (PCT): International filing system that lets you delay the expensive decision of which countries to file in. Buys ~18 months.

Defensive patent portfolio: Patents held not to sue competitors, but to deter lawsuits and enable cross-licensing. Common at scale.

Open Invention Network (OIN): Consortium that acquires patents specifically to protect Linux and open source projects. 3,000+ patents, royalty-free to members.

Trade secret: Confidential business information protected through secrecy rather than registration. Protection lasts until disclosed (accidentally or otherwise).

Copyleft: Open source licensing approach (e.g., GPL) that requires derivative works to also be open source. Prevents "embrace, extend, extinguish" by proprietary players.

Further Reading

• The Lean Startup, Eric Ries (execution-first thinking)
• Free Innovation, Eric von Hippel (open innovation economics)
• Open Invention Network: www.openinventionnetwork.com
• New Zealand IP Office: www.iponz.govt.nz
• WIPO PCT Guide: www.wipo.int/pct